专利信息

注册 | 忘记密码？

专利信息

Translation Company

查询条件展开筛选条件

[专利权人] 包含 'Bayer Schering Pharma Aktiengesellschaft'

[药品] 包含 'Spironolactone'

首页 1 尾页共 2 条记录, 当前第1/1页。

	公开号	公开日	申请号	申请日

	1. WO2011029782A1	2011/3/17	WO2010EP62964	2010/9/3
	专利标题：Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs 专利权人：Bayer Schering Pharma Aktiengesellschaft; The invention refers to the use of androgen receptor antagonists for the treatment and/or prevention of fibroids also known as uterine leiomyoma leiomyomata. Particularly the invention refers to the use of an androgen receptor antagonist being any one of the compounds according to the following list: cyproterone acetate oxendolone chlormadinone acetate spironolactone osaterone acetate dienogest flutamide hydroxyflutamide nilutamide bicalutamide RU 58841 LGD-2226 MDV3100 BMS-641988 BMS-779333 or ...

	2. DE102007011105A1	2008/9/4
	专利标题：Mineralcorticoid receptor antagonist for producing drug for permanent treatment of endometriosis, comprises spironolactone, eplerenone and drospirenone 专利权人：Bayer Schering Pharma Aktiengesellschaft; The mineralcorticoid receptor antagonist comprises spironolactone eplerenone and drospirenone. Glucocorticoid progesterone receptor antagonist and estrogen receptor antagonist are also included. The estrogen is ethinylestradiol. - ACTIVITY Gynecological. - MECHANISM OF ACTION Mineralcorticoid receptor antagonist; Gonadotropin-releasing hormone (GnRH) agonist.

首页 1 尾页共 2 条记录, 当前第1/1页。

当前查询条件: [专利权人] 包含 'Bayer Schering Pharma Aktiengesellschaft' AND [药品] 包含 'Spironolactone'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B